Edema disease is an acute, often fatal condition of swine caused by specific strains of Escherichia coli that produce Shiga toxin. This distinctive disease primarily affects recently weaned pigs during the critical transition period when they shift from sow milk to solid feed, typically striking one to two weeks following weaning. The condition derives its name from the characteristic accumulation of fluid in various tissues, particularly the stomach wall, eyelids, and brain, which produces the clinical signs that distinguish this disease from other post-weaning disorders.
Edema disease occurs worldwide in modern swine production systems and has been recognized as a significant cause of post-weaning mortality for decades. The disease typically affects the fastest-growing, healthiest-appearing pigs in a group rather than the weakest animals, which distinguishes it from many other infectious conditions. Morbidity rates within affected groups generally remain low at one to ten percent, but mortality among clinically affected individuals is high, often exceeding fifty percent despite treatment attempts. The sporadic nature of outbreaks and unpredictable timing challenge prevention efforts.
The economic impact of edema disease extends beyond direct mortality losses to include treatment costs, management disruption, and potential effects on surviving penmates. Affected pigs frequently represent the best genetics and growth potential in their groups, magnifying the loss when they succumb to disease. The stress of outbreaks on farm personnel and the disruption to production flow create additional intangible costs. Some farms experience recurrent problems requiring significant management changes or vaccination investments to control.
Understanding edema disease pathogenesis has improved significantly through research identifying the specific bacterial factors and host receptors involved. This knowledge has enabled development of targeted vaccines and genetic selection programs that reduce susceptibility. While treatment remains challenging once clinical signs appear, prevention through management strategies, vaccination, and potentially genetic selection offers meaningful protection. Early recognition of prodromal signs occasionally allows intervention before irreversible damage occurs.
